Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc, on whether payers will get more comfortable paying for one-time, curative therapies with high price tags.
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc, on whether payers will get more comfortable paying for one-time, curative therapies with high price tags.
Transcript
With more value-based agreements being introduced, do you think payers will become more comfortable with paying for one-time, curative treatments with high price tags?
Oh that’s much harder. I think the question of how we’re going to pay for, let’s start with [chimeric antigen receptor T] or gene therapy or whatever else the next thing is. I think we are not even close to a solution for that. In fact, we know, for example, that Medicare has completely fumbled the ball. They have not done very well with how they pay for CAR T. Now, mind you, CAR T is mostly inpatient right now. But the. [diagnosis-related group's] messed up, the outlier payments require that providing facility to literally lie about how much they spend on the drug. So, it’s all messed up
Commercial payers right now, because they’re relatively rare events, are just doing what commercial payers do. They negotiate on the individual patient level and as we’ve seen literally in the last 2 weeks, Cigna and CVS/Aetna has come out with let’s just call them old-school models for dealing with risk. Nothing very exciting. So, I’m hoping that as we get more therapies in this space, we’ll see some evolution in the thinking to a more innovative approach. For example, I love the idea of an outcomes-based contract. We haven’t really seen very many outcomes-based contracts in this space. I love that idea very much. I think the idea that we’re going to pay for value, the value that they bring, should resonate with all payers.
Now, there’s a very important proviso, and that is that these are in fact curative therapies, and if anybody thinks they know they are curative therapies, they’re nuts. The follow-up just has not been long enough and there haven’t been enough patients treated. So let’s hope that the science does in fact bare out and we do enjoy the kind of benefits that these therapies might provide us.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
2 Commerce Drive
Cranbury, NJ 08512